Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ICU MedicalSTU:IC7 80 PB Ratio is 2.12 as of Aug. 17, 2026, which is 21% below its 10-year median of 2.70. GuruFocus rates STU:IC7 with a GF Score™ of 80/100 and a GF Value™ of €105.79 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 782 Medical Devices & Instruments companies, ICU Medical ranks better than 50.51% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-17), ICU Medical's share price is €158.00. ICU Medical's Book Value per Share for the quarter that ended in Jun. 2026 was €74.69. Hence, ICU Medical's PB Ratio of today is 2.12.
Warning Sign:
ICU Medical Inc stock PB Ratio (=2.12) is close to 3-year high of 2.16.
The historical rank and industry rank for ICU Medical's PB Ratio or its related term are showing as below:
STU:IC7'
s PB Ratio Range Over the Past 10 Years
Min: 0.94 Med: 2.7 Max: 5.08
Current: 2.12
During the past 13 years, ICU Medical's highest PB Ratio was 5.08. The lowest was 0.94. And the median was 2.70.
STU:IC7's PB Ratio is ranked better than 50.51% of 782
companies
in the Medical Devices & Instruments industry
Industry Median: 2.145
vs STU:IC7: 2.12
During the past 12 months, ICU Medical's average Book Value Per Share Growth Rate was 0.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -0.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 3.20% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 8.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of ICU Medical was 131.90% per year. The lowest was -0.40% per year. And the median was 11.55% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
ICU Medical PB Ratio Related Terms
ICU Medical PB Ratio Historical Data
* Premium members only.
The historical data trend for ICU Medical's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, ICU Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's PB Ratio distribution charts can be found below:
* The bar in red indicates where ICU Medical's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
ICU Medical's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
ICU Medical (STU:IC7) has a PB Ratio of 2.12 as of Aug. 17, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on ICU Medical and its competitors. This is 21% below median its historical median of 2.70. Over the past decade, ICU Medical's PB Ratio has ranged from 0.94 to 5.08. According to the industry distribution chart, ICU Medical ranks #387 out of 782 companies in the Medical Devices & Instruments industry, placing it in the top 49.5%.
Is ICU Medical's PB Ratio too high?
ICU Medical's current PB Ratio of 2.12 is 21% below median its 10-year median of 2.70. Over the past 10 years, this metric has ranged from a low of 0.94 to a high of 5.08. The Medical Devices & Instruments industry median PB Ratio is 2.15. ICU Medical's value of 2.12 is 1.2% below this industry median. Based on the distribution chart, ICU Medical ranks #387 out of 782 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, ICU Medical has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ICU Medical's PB Ratio compare to NVST and MMSI?
According to the Medical Devices & Instruments industry distribution chart, ICU Medical ranks #387 out of 782 companies for PB Ratio. This puts ICU Medical in the upper half of its industry. The industry median PB Ratio is 2.15. ICU Medical's value of 2.12 is 1.2% below this benchmark. Historically, ICU Medical's own PB Ratio has ranged from 0.94 to 5.08 over the past decade. While the company's 10-year median is 2.70 vs. the industry median of 2.15, ICU Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.15, based on 782 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ICU Medical's current PB Ratio of 2.12 is 1.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on ICU Medical and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ICU Medical's current PB Ratio is 2.12, which is 21% below median its own 10-year median of 2.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICU Medical stock overvalued right now?
Based on GuruFocus' analysis, ICU Medical (STU:IC7) is currently considered Significantly Overvalued. The stock's GF Value™ is €105.79, compared to a current price of €158.00 — trading 49.4% above its estimated fair value. The current PB Ratio is 2.12, which is 21% below median its 10-year median of 2.70 and 1.2% below the Medical Devices & Instruments industry median of 2.15. ICU Medical's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For ICU Medical (STU:IC7), the current PB Ratio is 2.12 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ICU Medical (STU:IC7) Overvalued in 2026?
Based on GuruFocus' analysis, ICU Medical stock appears to be overvalued.
The current stock price of €158.00 is trading 49.4% above its estimated GF Value™ of €105.79.
GuruFocus considers ICU Medical to be Significantly Overvalued.
Key valuation signals for STU:IC7:
PB Ratio: 2.12 (21% below median its 10-year median of 2.70)
GF Value™: €105.79 vs. price of €158.00 (49.4% above fair value)
Industry Position: 1.2% below the Medical Devices & Instruments median (#387 of 782)
No single metric tells the full story. See the STU:IC7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
80GF Score
Get the complete analysis for STU:IC7
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:IC7 has been successfully added to your 
